Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza virus vaccine - Denka Seiken

Drug Profile

Influenza virus vaccine - Denka Seiken

Alternative Names: DNK FLU; DNK-651

Latest Information Update: 28 May 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Denka Seiken
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Influenza virus infections

Most Recent Events

  • 28 May 2019 No recent reports of development identified for phase-I development in Influenza-virus-infections(In the elderly, Prevention, In volunteers, In adults) in Japan (Intradermal)
  • 10 Dec 2018 Denka Seiken completes a phase II trial in Influenza virus infections (In volunteers, In adults, In adolescents, In children, Prevention) (Intradermal) in Japan (JapicCTI-173720)
  • 01 Oct 2017 Phase-II clinical trials in Influenza virus infections (In adults, In adolescents, In children, In volunteers, Prevention) in Japan (Intradermal) (JapicCTI-173720)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top